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INTRODUCTION 
The pept ide hormone relaxin consists of heterodimeric chains, an A chain 
of 22-24 amino acids and a B chain of 29-35 amino acids (Sherwood, 1994). 
Two chains are linked by two interchain disulfide bonds (Kemp and Niall, 1984). 
Relaxin is produced predominantly by corpus luteum during pregnancy and plays 
a very important role in pregnancy which affects the reproductive tract. 
Although a low level of relaxin activity was also detected in the nonpregnant 
ovary, uterus, placenta , testes, and prostate (Sherwood , 1 994), no circulating 
relaxin was found in these cases. The major biological functions of relaxin are: 
( 1) cervical softening, (2) pubic symphsis elongation to facilitate birth, (3) 
inhibition of spontaneous myometrial contractile activity to prevent premature 
birth, and (4) development of the mammary gland cells (Sherwood, 1994). In 
addition, it has also been reported that re laxin may act on male reproductive 
system, and it may be a central vasopressor and a peripheral vasodilator 
(Kakouris et al., 1993). Therefore, relaxin has been suggested as a hormone 
more than just for pregnancy. A recent study has demonstrated that specific 
relaxin receptor exists in male, female, and neonatal rat atria, and the receptor 
has a very high affinity very similar t o receptor in the uterus (Osheroff et al., 
1992). It has been shown that relaxin can increase heart rate both in vitro and 
in vivo (Ward et al., 1992). Increased contraction in the isolated atrium of rat 
was also observed (Kakouris et al., 1993). These data suggest that the heart is 
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one of the target organs for relaxin . However, no relaxin has been found in the 
peripheral circulation of male and neonatal rats, and the source of relaxin binding 
to cardiac relaxin receptor remains to be determined . Based on the fact that 
relaxin acts on some reproductive system via autocrine and/or paracrine routes, 
we hypothesized that the heart itself secretes relaxin. Preliminary experiment by 
Reverse hemolytic plaque assay support this hypothesis (Taylor and Clark, 
1994). However, Plaque assay can not localize and characterize relaxin . To 
further verify the preliminary result, we performed lmmunohistochemistry and 
Western blot analysis. Our results indicate that relaxin exists in atrium . 
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LITERATURE REVIEW 
History 
The pioneering work on relaxin was done by Dr. Frederick Hisaw in 1926. 
He showed that an aqueous extract of corpora lutea from pregnant sows caused 
interpubic ligament formation in estrogen-primed guinea pigs . The hormone 
contained in this aqueous extract was orig inally found to cause "relaxing" of the 
pubic symphysis, therefore the name "relaxin" was given. 
In the first two decades of relaxin research, progress was slow due to 
lack of interests in this field , and impure hormone preparations as well as 
limitations associated with the techniques. Then, research on relaxin increased 
during 1950's. Relaxin was found to cause elongat ion of the interpubic 
ligament in estrogen-primed mice, inhibition of the uterine myometrium 
contraction in estrogen-primed guinea pigs, and promotion of the cervical 
softening in estrogen-primed cattle (Sherwood, 1994). There was a decrease in 
the relaxin research during the period of 1960-1970 which was then fol lowed 
by an increase in 1970s. In 1972, radioimmunoassay was first used to measure 
relaxin in blood because the levels of relaxin were usually too low to be detected 
by other bioassays (Bryant et al., 1972). In 1974, the purification of porcine 
relaxin was the most significant breakthrough at that time and this al lowed 
scientists to conduct much subsequent research (Sherwood and O'Byrne, 
1974) . Subsequently, relaxin was highly purified from the rat (Sherwood, 
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1979). The most significant event was the determination of the primary 
structure of porcine relaxin by two independent groups in 1 976 and 1 977 
(Schwabe et al., 1976, 1977; James et al., 1977) . During the past two 
decades many new information were reported including the recognition of 
human corpus luteum and placental relaxins, the cloning of the rat relaxin gene, 
the measurement of plasma hormone and tissue receptor concentrations, and 
the induction of cervical distensibility in pregnant women , swine, and cattle 
(Sherwood, 1994). The availability of synthetic and recombinant relaxin by 
gene cloning and expression techniques has triggered an increase in relaxin 
research. In addition to ovary, relaxin is now believed to be produced in many 
other tissues, such as the placenta (Sakbun et al., 1990), endometrium (Bryant-
Greenwood, 1991 ), the prostate gland of the male (Sokol et al., 1989), and that 
relaxin is secreted in "milk" (Eddie et al., 1989). In addition, relaxin has been 
shown to have effects on the release of vasopressin and oxytocin from the 
neurohypophysis (Dayanithi et al., 1987). The sites of activity of relaxin can be 
detected by using autoradiographic techniques with the biologically active 32P-
labeled human relaxin . These studies show displaceable binding of relaxin to the 
rat brain and heart as well as to the uterus and cervix (Osheroff et al., 1990, 
1992 and Osheroff and Phillips, 1991 ). 
Recently, several lines of evidences have implicated a possible role of 
relaxin in the control of blood pressure. It was found that relaxin can cause a 
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sustained increase in arterial blood pressure when relaxin was administered to 
normotensive rats via the third cerebral ventricle (Mumford et al. , 1989; Parry 
and Summerlee, 1991 ) . Relaxin, however, can directly stimulate rat atrial 
activity in vitro and cause chronotropy in vivo (Ward et al., 1992). 
Structure of relaxin 
Relaxin is a protein with a molecular weight of approximately 6-kDa, it 
has a basic isoelectric point and contains two interchain disulfide bonds that are 
essential for biologic activities (Sherwood, 1994). Surprisingly, there are very 
similar superficial structural characteristics between porcine relaxin and insulin. 
The A and B chains of porcine relaxin and insulin are about the same size and 
their disulfide bonds are located in the same positions (Fig. 1). Although only 
1 2 of 49 aligned amino acid residues are identical between porcine relaxin and 
insulin (Fig . 2), the three-dimensional structure of relaxin is similar to that of 
insulin (Sherwood, 1994). Therefore, relaxin is classified as a member of the 
insulin-like growth factor family including insulin-like growth factor (IGF), and 
insulin (Blundell and Humbel , 1980). 
The relaxin and insulin are very similar in their structural conformation, 
but their sequences differ by approximately 70% . More surprisingly, the 
sequence of insulin is conserved among species, but the sequences of relaxins 
from different species varied by 45-60 % (Sherwood, 1994). Although stringent 
Insulin 
Relax in 
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Fig. 1. Covalent structure of porcine insulin and relaxin . 
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B chain 
Insulin 
F V N Q H L .c.__G_ S H L._J[ E A L Y L V .c.__G_ E R G F F Y T P L A 
Relaxin 
<Q S T N D F I K A .c.__G_ R E L._J[ R L W V E I .c.__G_ S V S W G R T A L 
A chain 
Insulin 
G I V E Q .c....J: T S I C S L Y Q L E N Y C N 
Relaxin 
R M T L S E K .c....J: Q V G C I R K D I A R L C 
Fig. 2. Amino acid sequences of porcine insulin and relax in. The 
sequences were aligned Fig to match at the cysteine residues. Identical amino 
acid residues were underlined. 
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requirements to maintain similar tertiary structures exist, relaxin and insulin do 
not share common biologically active sites (Sherwood , 1994). Competitive 
binding studies showed that the receptor-binding domains of relaxin and insulin 
are different. Porcine insulin bound to insulin receptor on rat brain cortex could 
not be displaced by porcine relaxin (Gammeltoft et al, 1984). Furthermore, 
porcine relaxin could not be displaced by porcine insulin from relaxin receptors 
on human skin fibroblasts (McMurtry et al. , 1980) and rat uterine myometrium 
(Mercado-Simmen et al., 1980). Several evidences also indicated that there 
were no common biologic activity between relaxin and insulin in mammals 
(Sherwood, 1994). For example, porcine relax in has no effect on blood glucose 
in rat (Vasilenko et al., 1980, 1982). 
The cysteine residues in the A and B chains are conserved in all relaxins 
of different species (Fig. 3) . The disulfide bonding pattern for relaxins and 
insulins are involved in the part of the basic functional structure. 
A chain : The a-helix N-terminal portion of the A chain appears to be 
important for relaxin activity . Selective removal of amino acids from the N-
terminal section of the porcine relaxin A chain led to the inactivation of relaxin 
activity (Bullesbach and Schwabe, 1 986) . The activity of relaxin could also 
return when these residues were replaced with other amino acids (Bu llesbach 
and Schwabe, 1 987). These experiments indicated that the a-helix N-terminal 
portion of A chain was important, but special amino acid residues are not 
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B chain 
Rat 
R V S E E W M D Q V I Q V ~ G Y A R A li I E V ~ A S V G R L A L 
Pig 
<Q S T N D F I K A ~ E L V R L N V E I ~ S V S W G R T A L 
A chain 
Rat 
< Q S G A L L._S__E Q .c__c. H I G_C T R R S .LA K L.__C 
Pig 
R M T L._S__E K .c__c. Q V G_C I R K D .LA R L.__C 
Fig. 3 . Amino acid sequences of rat and pig relaxin B and A chains. 
The sequences were aligned to match at the cysteine residues. Identical amino 
acid residuces were underlined. 
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required. 
B chain : Unlike A chain which is variable only at the N-terminus, the B 
chain varies in length at both N- and C- terminal ends (Bryant-Greenwood and 
Schwabe, 1994) . The biologic activity of relaxin did not require the complete C 
terminus of the B chain. Although the B chain of relaxin appears to carry the 
receptor interaction site and mediates the biological response, the B chain alone 
has no activity and does not prevent the binding of intact relaxin from its 
receptor (Bryant-Greenwood and Schwabe, 1994) . So both A chain and B chain 
are important for relaxin . 
Prorelaxin structure 
Relaxin , like insulin, is originally synthesized as a single chained 
preprohormone. The overall structure of the preprorelaxin contains signal 
peptide/B chain /connecting peptide/A chain, as show diagrammatically in 
Fig . 4. 
The signal peptides for porcine and rat preprorelaxin contain 22 to 25 
amino acid residues. The preprorelaxin and prorelaxin , which are 23-kDa and 
19-kDa, respectively, are larger than preproinsulin and proinsulin which are 11 -
kDa and 9-kDa, respectively (Frieden and Yeh , 1977; Gast, 1982, 1983; Kwok 
et al., 1 978) . The size differences between relaxin and insulin precursors are 
largely due to the differences in the lengths of the connecting (C) peptides. The 
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c 
B 
A 
preprore laxin 
c 
B 
A 
prorelaxin 
B 
A 
re laxin 
Fig . 4. Schematic summary of the process ing of the preprorelaxin to 
the native relaxin (A chain and B chain) with the successive removal of the 
signal (S) peptide and the connecting (C) peptide by proteolytic cleavage. 
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C peptides in porcine (Haley et al. , 1982) and rat relaxin (Hudson et al., 1981 ), 
fo r example, contain 104 or 105 residues, respectively. However, porcine and 
rat proinsulin contains only about 30 residues (Tager and Steiner, 1972). The 
function of the C peptide in relaxin is not known . It has been reported that the 
C peptide may direct the folding of the precursors so t hat correct disulfide bonds 
are formed between the B and A chains. The C peptide may contain peptide 
sequences w ith hormonal activities because of its large size and conserved 
primary structure among species (Hudson et al., 1981 ; Kemp and Nial l, 1984). 
It remains to be determined whether the C peptide exhibits hormonal activity. 
Distribution of relaxin 
Ovary and prostate 
Although the corpus luteum is the classical production site of the relaxin 
that enters the systemic ci rculation in females during pregnancy, relaxin is also 
produced with in preovulatory foll icles (Evans et al. , 1983; Denning-Kendall et 
al. , 1989; Bagnell et al., 1990) . It has been reported that relaxin production 
predominates during the luteal phase of t he estrous cycle and then declines to 
low levels after luteolysis (Anderson et al., 1973). A bioactive equivalent of 
relaxin was reported in rooster testicular extracts which was later proved to be 
relaxin (Sherwood, 1994). In 1992, Winslow et al. reported that seminal relaxin 
was isolated from human seminal plasma and found that its structure is the 
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same as human relaxin 2 produced by the human corpus luteum . So far, the 
prostate gland is considered to be the sole source for human relaxin in the male 
(Sokol et al., 1989). However, this source of relaxin is too low to be detected 
in circulation. Relaxin is likely to be secreted directly into prostatic fluid 
(Winslow et al. , 1992) . The glandular epithelium of the prostate gland was 
shown to synthesize relaxi n (Sokol et al., 1989). The mRNA transcripts of 
human relaxin gene was detected in prostate but not the t estes (lvell et 
al., 1989). 
Uterus and placenta 
Relaxin immunoactivity was detected within endometrial gland epithelial 
cells during the luteal phase of the menstrual cycle (Yki-J arvinen et al., 1983, 
1985). Relax in was also shown to exist in the decidua through early pregnancy 
and the menstrual cycle (Sherwood, 1994) . These results indicat ed that 
endometrium and decidua are additional sources of relaxin in the menstrual 
cycle. Thus , an autocrine/paracrine interplay of endometrial peptides is 
important for endometrial epithelium and stroma growth and differentiation. The 
placenta was also shown to be a sit e of relax in production (Bryant-Greenwood, 
1991 ). 
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Breast/ Mammal 
Several lines of evidences indicated that relaxin is produced within the 
human breast regardless of the reproductive status of the woman (Nardi et al., 
1983; Eddie et al., 1989; Bongers-Binder et al., 1991 ). It has been reported 
that transcription of the human relaxin genes exists in extracts of benign and 
neoplastic breast tissues (Sherwood, 1994). 
Other possible sources of relaxin 
Many possible novel sites of relaxin production have been studied in both 
man and animals by using different techniques. It has been shown that relaxin 
is produced in the human gastrointestinal tract, and that the relaxin-like 
immunoactivity is present in specific cell types in the stomach, duodenum, and 
colon {Bryant-Greenwood and Schwabe, 1994). Relaxin was also shown to be 
produced in the rat brain {Osheroff and Ho-WH, 1993). The relaxin binding sites 
in rat brain were localized, suggesting a possible role of relaxin in rat brain 
maturation (Osheroff and Ho-WH, 1993; Osheroff and Phillips, 1991 ). 
Blood levels of relaxin 
Circulating relaxin levels are elevated throughout nearly all gestation in the 
human {Sherwood , 1994) . Many studies were conducted using women without 
corpora lutea, receiving donated ova to explore the sources of circulating relaxin 
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in the early pregnancy (Emmi et al., 1991; Johnson et al., 1991 ). The results 
showed that the primary source of circulating relaxin is from the corpus luteum, 
however, a minor source of extraluteal relaxin in such women may be the 
endometrium and decidua (Bryant-Greenwood and Schwabe, 1 994). In contrast 
to pig and rat, which have a sharp increase in relaxin bioactivity in plasma 
obtained from peripheral blood before birth (Sherwood, 1994), there is no 
antepartum increase in relaxin levels in women (O ' Byrne et al., 1978; 
Ouagliarello et al., 1980). A direct relationship between the amount of luteal 
tissue present and the blood relaxin level in pregnancy was suggested. The 
studies of twin pregnancy as compared with those in normal singleton 
gestations have further indicated this relationship. There were higher circulating 
relaxin levels in a twin gestation (Norman et al., 1993). This elevated level of 
circulating relaxin is likely due to the larger number of maturing follicles and/or 
the enhanced maturation of their relaxin synthetic activity (Johnson et al. , 
1991 ). 
Clearance of relaxin from the blood 
The results from the studies of the clearance of human relaxin from the 
serum of both monkeys (Ferraiolo et al., 1 991) and rats (Coss um et al., 1 992) 
showed that relaxin is cleared from the circulation by the kidney and liver. The 
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terminal half-life for clearance of human relaxin 2 in monkeys and rats was 
approximately 150 and 60 min., respectively. 
The possible biological actions of relaxin 
General overview 
It is generally believed that relaxin is a hormone associated with 
pregnancy since it is produced primarily by the corpus luteum of the ovary 
during pregnancy (Sherwood, 1994) . The two major biological activities of 
relaxin in animals are the rapid inhibition of myometrial activity and a slow 
change in the structure of connective tissue at its target sites in preparation for 
parturition (Sherwood , 1994). 
Recent studies with highly purified relax in demonstrated that, in addition 
to the effects on the pubic symphysis, cervix, and myometrium, relaxin also 
influences other reproductive tissues and nonreproductive tissues (Kakouris et 
al., 1993) . Indeed, some novel target sites for human relaxin, such as the brain 
and atrium of the heart, have been found in the rat (Osheroff and Ho-WH, 1993; 
Osheroff et al., 1992; Osheroff and Phillips, 1991 ). 
Relaxin appears to have a peripheral vasodilator effect predominantly on 
the venous circulation (Bigazzi et al., 1986). Also, relaxin exerts a central 
pressor effect partly due to vasopressin release. It was shown that exogenous 
relaxin can increase heart rate in normotensive and spontaneously hypertensive 
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female rats (Ward et al., 1992) as well as in anesthetized rats (Parry et al., 
1990). Relaxin was shown to act directly on the heart and the action was 
probably mediated through specific relaxin receptors (Kakouris et al. , 1993). 
High levels of relaxin receptors can be detected in the cardiac atrium of the rat 
as early as 1 day after birth (Osheroff and Ho-WH , 1993). These studies 
indicate that relaxin has many other functions besides acting as a hormone of 
pregnancy which affects mainly the female reproductive tract . 
Collagen 
Relaxin is believed to play a role in connective tissue remodeling during 
pregnancy (Sherwood, 1994) . Exogenous relaxin was shown to cause a 
relaxation of interpubic ligaments in estrogen-primed virgin animal (Talmadge , 
1 950) and a decrease in the density of collagen bundles present in the ligament 
(Chihal and Espey, 1973). Porcine relaxin was also shown to cause a decrease 
in collagen synthesis in human cervical and uterine explants (Wiqvist et al. , 
1 984), and was also shown to modulate the release of connective tissue-
degrading enzymes in tissues of the rat uterus and cervix (Too et al. , 1986) and 
granulosa cells (Too et al. , 1984). The effect on collagen remodeling may be a 
biological consequence of systemic relaxin as well as locally produced relaxin in 
the reproductive tract. It has been hypothesized that local relaxin can act in an 
autocrine/paracrine mode which may be involved in collagen remodeling in the 
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reproductive tract (Bryant-Greenwood, 1982) . Release of relaxin in the 
connective tissue led to increased distensibility and plasticity of the tissue and 
to a quiescence of smooth muscle. The action of relaxin in connective tissue is 
probably mediated by a series of enzyme changes, and these changes may be 
identical in all of the target tissues (Sherwood , 1994) . 
An in vitro study using normal human dermal fibroblasts with 
homogenous re laxin demonstrated that re laxin can remodulate collagen 
synthesis and secretion (Unemori and Amento, 1990). The result showed that 
human dermal fibroblasts respond to human relaxin with a dose-related increase 
in both mRNA and protein levels for interstitial collagenase . Meanwhile, relaxin 
caused a modest decrease in expression of the col lagenase inhibitor and the 
collagen secretion. Therefore, the effect of relaxin in conncetive tissue is 
decreasing production and increasing breakdown of collagen (Unemori and 
Amento, 1990). 
Myometrium and smooth muscle 
Relaxin is a potent inhibitor of uterine contraction. However, the action is 
very rapid , and once the hormone is cleared from the circu lation, the uterus 
quickly returns to full contractile activity (Sherwood, 1994). Difference in the 
potencies of relaxin among species as inhibitors of uterine contractions exists. 
Porcine relaxin is effective in inhibiting contractions in uterine tissue from most 
19 
species, including rats, pigs and rabbits, but the porcine relaxin has little effect 
on human myometrial activity (Bryant-Greenwood and Schwabe, 1994). Relaxin 
may be important in inhibiting uterine contractions during the antepartum period 
(Sherwood, 1994). Also, relaxin may increase sensitivity of the myometrium to 
oxytocin that generates highly coordinated labor contractions (Bagnell et al., 
1993). 
At the biochemical level the mechanism of the rapid action of relaxin on 
uterine and cervical smooth muscle may be mediated by several post-receptor 
signal-transduction mechanisms, which include generation of cAMP, opening of 
plasma membrane potassium (K +) channels and change in intracellular Ca ++ 
concentration (Downing and Hollingsworth, 1 993). 
Unlike skeletal muscle, smooth muscle is not regulated by a troponin-
tropomyosin mechanism which is characteristics of card iac and skeletal muscles 
(Stryer, 1988). Instead, smooth muscle contraction is controlled by the degree 
of phosphorylation of its light chains . Phosphorylation of smooth muscle light 
chains of myosin leads to contraction, and dephosphorylation results in 
relaxation . Calcium ions bound to calmodulin activate myosin light-chain kinase 
that phosphorylates the light chains of myosin, and leads to contraction. A 
cascade mediated by cAMP leads to the relaxation of smooth muscle by 
phosphorylating this light-chain kinase, which lowers its affinity for Ca + + -
calmodulin (Stryer, 1988). Many hormones influence smooth muscle 
20 
contraction. In the uterus, acetylcholine, oxytocin, angiotensin, and 
prostaglandin stimulate contraction, whereas relaxin and P-adrenergic agonists 
cause relaxat ion. Nishikori et al. ( 1983) reported that relaxin inhibited uterine 
myosin light chain phosphorylation from estrogen-primed rats, suggesting that 
relaxin may contro l uterine myosin light-chain kinase through a regulatory 
cascade similar to that for the p-adrenergic system which triggers the adenylate 
cyclase cascade in smooth muscle cells . 
Relaxin-dependent increase in uterine cAMP is believed to be a direct 
effect of relaxin rather than the consequence of release by another hormone 
(Downing and Hollingsworth , 1993). However, whether cAMP is an essential 
intracel lular mediator for relaxin or whether the changes in cAMP are secondary 
to other events rem ains unknown. It is known that the uterus contains a 
calcium-calm odulin-dependent phosphodiesterase (Downing and Hollingsworth, 
1 993) . Thus, any hormone that lowered uterine intracellular calcium could 
potentially inhibit phosphodiesterase and thereby elevat e cAMP levels . It is 
known that relaxin has effect on uterine ca lcium f luxes (Downing and 
Hollingsworth, 1993). 
Recently, it has been shown that relaxin can stimulate K + channel 
opening (Downing and Hollingsworth, 1993). The consequence of K + channel 
opening is hyperpolarization, which leads to the c lose of the influx of Ca ++ via 
voltage-operated channel. The reduction in influx of Ca ++ results in low 
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intracellular Ca ++ concentration which, in turn , favors phosphorylation of 
myosin light-chain kinase (Downing and Hollingsworth, 1993). However, relaxin 
was also found to increase Ca ++ efflux in rat uterine tissue in vitro and in 
cultured rat myometrial cells (Ginsburg et al., 1988; Rao and Sanborn, 1986). 
This action may be secondary to earlier biochemical or ion channel changes. 
Blood pressure 
Recent studies suggest that relaxin may play a role in the control of blood 
pressure. Gestation in human and rats is generally associated with a certain 
decrease in blood pressure (Kakouris et al., 1993). In the rat , the decrease in 
the blood pressure is accompanied by increase in relaxin secretion (Crish et al., 
1986; St-Louis and Massicotte, 1985) . After birth , the level of relax in in 
circulation declines, and this is associated with an increase in blood pressure 
(Sherwood et al., 1980). In humans, the decline in blood pressure is also 
associated with an inc rease in relaxin secretion, particularly, in the first trimester 
of pregnancy (Kakouris et al. , 1993). Blood pressure increases just before 
parturition at which relaxin disappears from plasma (St-Louis and Massicotte, 
1985). 
Mixed results were obtained with animal experiments on the 
cardiovascular effects of relaxin (Jones and Summerlee, 1986, 1987; Mumford 
et al. , 1989; Parry et al., 1990; St-Louis and Massicotte, 1985; Ward et al., 
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1991) . Both hypo- and hyper-t ensive effects were observed when relaxi n is 
administered intravenously . When spontaneously hypertensive rats were 
infused chronically via intravenous injection with porc ine relaxin, the blood 
pressure decreased and susta ined (St-Louis and M assicotte, 1985) . Topical 
application of relaxin to the mesenteric vasculature of rats produced a 
vasodilation (Massicotte et al., 1989). When relaxin was infused either the 
lateral or dorsal portion of the third cerebral ventricle, blood pressure rose 
significantly and sustained. However, when relaxin was administered to the 
ventra l portion of the third cerebral ventricle, only a short-term ri se in blood 
pressure occurred (Mumford et al., 1989). A principal mediator of the 
hypertensive action of relaxin appears to be vasopressin (VP). Blockade of 
peripheral VP action on V1 receptors almost completely inhibits the presser 
response to intraveneous injection of relaxin (Parry et al. , 1 990) . It has been 
reported that relaxin causes the release of VP from the isolated neural lobe when 
the nerve endings were stimulated (Dayanithi et al. , 1987). These findings 
suggest that relaxin may act directly on the brain . Recent studies demonstrated 
that human relaxin can specifically bind to localized reg ions of the cortex, 
hypothalamus, thalamus, hippocampus, amygdala, midbrain and medulla of both 
the male and female rat brain (Osheroff and Phillips, 199 1 ), suggesting a 
possible central action of this hormone. It is known that both subfornical organ 
and the organum vasculosum of the lamina t erminals are involved in the 
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regulation of blood pressure, and both paraventricular and supraoptic nuclei are 
involved in control of vasopressin and oxytocin release. Relaxin may have both 
peripheral and central action in regulation of blood pressure . Peripheral action of 
relaxin is predominantly vasodilator effect, but the mechanism remains 
unknown. Central action of relaxin is presser effect, which is mediated possibly 
by release of VP and angiotensin at specific sites located in the subfornical 
organs (Kakouris et al. , 1993). 
Heart 
During human pregnancy, cardiac output increases at the first trimester 
approximately 40% before the uterus or fetus show any marked increase in size 
(Kakouris et al., 1993). Since relaxin can increase the rate and force of cardiac 
contraction, relaxin may also be responsible for the increase in cardiac output 
observed during the first trimester of pregnancy. Recent studies showed that 
the action of relaxin is directly on the heart and is probably mediated through 
specific relaxin receptors. Using isolated, spontaneously beating right atrium 
and electrically driven left atrium of the rat, human relaxin gene 2 product was 
found to cause dose-dependent positive chronotropic effect in right atrium and 
inotropic effect in left atrium (Kakouris et al., 1992). The results indicate that 
the action may be directly on specific receptors in the rat isolated atria. The 
results also show that the potency of human relaxin gene 2 product is greater 
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than that of endothelin, angiotensin II, and (-)-isoprenaline in isolated rat atria 
(Kakouris et al., 1992). Kakouris et al. ( 1992) showed that pretreatment of 
reserpine to remove catecholamines produced only a small shift to the right of 
the dose-response curves for human relaxin gene 2 product. The shift for the 
chronotropic effect was significant, whereas that for the inotropic effect was 
not. After pretreatment with reserpine, blockade of P-adrenoceptors with 
propranolol, a-adrenoceptors with phentolamine, or 5-HT2 receptors with 
methysergide, only minor and insignificant shifts to the right of the dose-
response curve for both chronotropic and inotropic effects were observed 
(Kakouris et al. , 1992). These results indicate the existence of a specific relaxin 
receptor in the heart. 
Further evidence for a specific relaxin receptor in the heart comes from 
binding studies using 32P- labelled relaxin (Osheroff et al., 1992). Osheroff et al. 
( 1992) demonstrated that the heart atrium of both female and male rats 
contains sites that bind 32P- labeled human relaxin 2 with both specificity and 
high affinity. The dissociation constant for relaxin in the atrium was similar to 
that in the uterus. However, unlike the uterus, relaxin binding in the heart was 
not affected by castration or estrogen administration . Han et al. ( 1994) 
reported the possible mechanism of these chronotropic and inotropic effects of 
relaxin . Using single cell isolated from the sinoatrial node of rabbit hearts, they 
found that relaxin increases L-type calcium current, I ca (L), by view of the cAMP 
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formation and cAMP- dependent protein kinase (PKA) activity. Therefore, 
relaxin acts in a similar way to ~-adrenergic agonists. The discovery that relaxin 
has powerful inotropic effect is particularly exciting since it could be developed 
to be a novel, potential inotropic agent. 
26 
MATERIALS AND METHODS 
Animal 
3-day-old male and female Sprague-Dawley rats were used. 
Reagents 
The reagents for Protein assay and Western blot were purchased from 
Bio-Rad Lab (Richmond, CA) . All reagents were analytic grade. The system 
used for electrophoresis and electrotransfer was also purchased from Bio-Rad. 
lmmunohistochemistry 
The rats w ere sacrificed, and the heart of each rat was fixed in 10% 
Neutral buffered fo rmalin (NSF) solution for 18 hours . The heart tissues were 
dehydrated , paraffin-embedded and sectioned seria lly at 5 µm , and mounted on 
glass slides. Following deparaffinization and rehydration , the sections were 
treat ed with 3 % H20 2 for 30 min . and t hen incubated with 5% Normal goat 
serum (NGS) fo r 20 min. at room temperature. The sections were then 
incubated with the primary antibody, rabbit anti -porcine relaxin antibody 
(donated by Dr. Sherwood) 1 :750 diluted with Tris/PBS buffer (Appendix A) for 
30 min . at room temperture . Further incubation was performed with 
biotinylated goat anti-rabbit lgG ( 1 :200; Vector, Burlingame, CA) and then with 
Avidin-Biotin-Peroxidase complex (ABC) (Vector) at room temperature for 1 
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hour. After each step, sections were rinsed thoroughly in Tris -base buffer (pH 
7 .2) 3 times. Staining for peroxidase was performed using metal enhanced 
3'3'-diaminobenzidine tetrahydrochloride (DAB) kit (Pierce, Illinois) for 5 min . 
Each section was then counterstained with hematoxylin, and mounted. 
lmmunostained sections were examined under microscopy . The presence of the 
brown color in the cells indicates a positive result. lmmunohistochemistry 
protocol is provided in Appendix A. For negative controls, the primary antibody 
and the secondary antibody were replaced with Tris /PBS buffer, respectively. 
Normal rabbit serum (NRS) and Tumor narcosis factor (TNF) antiserum, 
respective ly, instead of primary antibody, were also used as control. To 
compare the locations of relaxin and atrial natriuretic peptide (ANP) in the heart 
tissue of the neonatal rat, serial sections were also stained with primary ANP 
antibody by immunohistochemistry study as described for relaxin. The ABC 
method is diagraphically shown in Appendix C. 
lmmunoblot 
Protein extract 
The atrial tissues of 20 rats , including auricle, were homogenized in cold 
Phosphate-buffer saline (PBS; pH 7 .2) with homogenizer. The homogenates 
were clarified by low speed centrifugation at 1 500 Xg for 10 min. The 
supernatant was harvested and recentrifuged at 21 ,000 rpm for 90 min. at 4 °C 
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to sediment cellular organelles, such as, mitochondria, lysosomes, and cellular 
debris . The resulting supernatant was aliquoted and stored at -20 °C until use in 
Western blot analysis. 
Protein assay 
Atrial extracts were assayed for total protein using a Bio-Rad protein 
assay kit (Bio-Rad labs, Richmond , CA) , following the Laboratory instructions. 
The concentration of the proteins in the extracts was calculated. The protein 
concentration of rat atrial extract is 3 .5mg/ml. The volume of each protein 
sample loaded in the same gel was adjusted to contain the same amount of total 
proteins . 
Sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PA GE) 
SOS-PAGE was used to evaluate protein content of crude atrial extracts. 
Samples dissolved in SOS sample buffer (Appendix B) were loaded onto 1-mm-
thick, 1 2 % polyacrylamide minigels ( Bio-Rad Mini-Protean 2 apparatus ) , and 
electrophoresis was conducted through use of a running buffer system 
(Appendix B). Gels were run at constant voltage 200 volts (start/finish: 200 V, 
50 mA/200 V, 30 mA) for 30 min. 
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Western blot analysis 
After SOS-PAGE, gels were equilibrated in transfer buffer and transferred 
to nitrocellulose membrane (0.2-µm pore size; Bio-Rad) in ice cold transfer buffer 
(Appendix B). Transfer was conducted at constant voltage 100 volts 
(start/ finish: 100 V , 164 mA/ 100 V, 214 mA) for 1 .5 hours. The nitrocellulose 
membrane was washed two times with Western buffer (Appendix B) and 
agitated in 1 % Bovine serum albumin (BSA) to block nonspecific reaction for 18 
hours. The blocked nitrocellulose membrane was incubated with Rabbit anti-
porcine relaxin antibody (#258, donated by Dr.Sherwood) diluted 1 :200 in 
Western buffer for 1 hour at room temperature with gentle agitation and then 
washed twice (10 min. each) with Western buffer . The membrane was then 
incubated with Biotinylated goat-antirabbit lgG (Bio-Rad) for 1 hour at room 
temperature and washed as before . The membrane was further incubated with 
Streptavidin-biotinylated alkaline phosphatase complex at room temperature for 
1 hour. Bound relaxin antibody was visualized by incubation with alkaline 
phosphatase substrate {5-bromo-4-chloro-3-indolyl phosphate/nitroblue 
tetrazolium; Bio-Rad) . The Streptavidin-biotinylated-alkaline phosphatase 
complex method is diagraphically shown in appendix D. 
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RESULTS 
The localization of relaxin has been investigated by immunohistochemistry 
method in the heart of rat . Antibody against the porcine relaxin was raised in 
rabbits. Result obtained by immunohistochemistry showed that atrial 
cardiocytes, especially auricle, had a positive reaction and the ventricular 
cardiocytes were consistently negative (Fig . 5, 6, 7 , 8, 9, 10, 11, 12). The 
positive reaction was characterized by brown color located in the cytoplasm of 
the cardiocytes. 
To further confirm the presence of relaxin in the atrial tissue, extracts of 
the rat and pig atria were examined by using Western blot after the 
electrophoretic transfer from SDS-polyacrylamide gels to nitrocellulose 
membrane. Two bands with molecular weights of approximately 18-kDa and 
23-kDa, respectively, were immunostained both in the atrial extracts of rat and 
pig (Fig. 13, 14). The 18-kDa and 23-kDa immunostained bands in the atrial 
extracts of rat and pig were likely the prorelaxin and preprorelaxin, respectively, 
as two similar bands were immunostained in the extracts of porcine corpus 
luteum (Fig. 14) . However, the prorelaxin and preprorelaxin in the atrial extracts 
of rat and pig were slightly larger in size than that of the porcine corpus luteum 
which were 16.5-kDa and 21.5-kDa , respectively (Fig . 14) . 
Fig. 5. Negative control with Tris/PBS buffer instead of 
primary antibody. No immunostaining was found in the specimen. 
Fig . 6. Negative control with Tris/PBS buffer instead of 
secondary antibody. No immunostaining was found in the specimen. 

Fig . 7. Negative control with 1 : 500 diluted normal rabbit 
serum instead of primary antibody. No immunostaining was found in the 
specimen. 
Fig . 8 . Negative control with 1: 500 diluted rabbit anti-TNF 
antibody. No immunostaining was found in the specimen. 

Fig . 9 . Rat heart tissue prepared by immunohistochemical 
staining utilizing horseradish peroxidase technique. Nuclei counterstained 
with hematoxylin appear blue . Relaxin appears as brown color located in 
myocardiocytes. No immunostaining was found in ventricle . Original 
magnificant X25 . 
Fig. 10. Detail of part of rat atrium stained as in figure 9. 
Positive reactions are found in the cytoplasm . Original magnificant 
X105. 
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Fig . 11 . Low power view of left atrium (LA) and part of left 
ventricle of rat stained by immunoperoxidase technique with relaxin 
antibody. Hematoxylin counterstain. Ventricular myocardiocytes are 
unstained, but myocardiocytes of the atrium are immunostained. 
Fig. 12. Low power view of left atrium (LA) and part of left 
ventricle of rat stained by immunoperoxidase technique with ANP 
antibody. Hematoxylin counterstain. Ventricular myocardiocytes are 
unstained, but myocardiocytes of the atrium are immunostained. 
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Fig. 13. Western blot analysis of rat atrial extracts with different concentrations, 17. 5 µg 
(Lane A 1) , 21 µg (Lane A2), 28 µg (Lane A 3) , 35 µg (Lane B1) , 42 µg (Lane B2), 56 µg (Lane B3) , 
respectively . Low range prestained SOS-PAGE standard was used as marker (lane M) . An approximately 
18-kDa (.A) band was immunostained in all concentrations of extracts . An additional band of 
approximately 23-kDa (<1 ) was immunostained in higher concentrations of extracts. 
A 1 2 3 
<l <l 
B 1 2 3 
<l 
M kDa 
351 
29.7 
~-21.9 
M kDa 
35.1 
29.7 
- 21 .9 
+::-
0 
Fig . 14. Western blot analysis of porcine corpus luteum extract (Lane A), porcine atrial extract 
(Lane 8), porcine kidney extract (Lane C) and rat atrial extract (Lane 0). Low range prestained SOS-PAGE 
standard was used as marker (lane M) . Note both rat and porcine atrial extracts contain an 
approximately 1 8-kDa prorelaxin (.A.) and an approximately 23-kDa preprorelaxin ( <l), but the sizes of 
prorelaxin and preprorelaxin in porcine corpus lute um are about 1 6 . 5-kDa (.A.) and 21 . 5-kDa ( <l), 
respectively . 
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--~...---..,..- ' 
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DISCUSSION 
Relaixn is a 6-kDa peptide hormone which is composed of two peptide 
chains (A- and B-chains) linked by two interchain disulfide bonds (Bryant-
Greenwood and Schwabe, 1994). A lthough relaxin play an important role in 
reproductive tract during pregnancy (Sherwood, 1 994), it also has function in 
cardiovascular system (Kakouris et al. , 1992). Recently, increased evidences 
indicate that relaxin involved in regulation of blood pressure in view of peripheral 
and central system (Kakouris et al. , 1993) . More recently , relaxin was found to 
directly stimulate rat atrium and cause chronotropy and inotropy in vitro and in 
vivo (Kakouris et al. , 1992; Ward et al. , 1992) . It was also demonstrated that 
relaxin can bind to rat heart atrium via specific receptor regardless of sex, age, 
and reproductive status (Osheroff et al., 1992). However, reproductive system 
remains immature during neonatal period, and no circulating relaxin occurs . 
Other studies indicated that male rat has also no circulating relaxin. The 
question raised is what is the source of relaxin binding to rat atrium. 
Our experiments have employed two separate approaches to detect 
relaxin in the heart tissues. ( 1 ). By using a sensitive immunohistochemistry 
technique and an antiserum against purified porcine relaxin , we showed that 
relaxin immunostaining was confined to the atrium . No immunostaining was 
found in ventricle . This result suggests that the atria may be the storage site for 
relaxin in the rat. (2). By using immunoblotting technique, we demonstrated 
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that the precursors of relaxin exist in the atrial extracts of rat . The molecular 
weights of the prorelaxin and preprorelaxin in rat atrial extracts are about 1 8-
kDa and 23-kDa, respectively . The prorelaxin and preprorelaxin detected in the 
pig atrial extracts have the same molecular weights. Interestingly, the atrial 
prorelaxins and preprorelaxins detected in rat and pig are slightly larger in size 
than that detected in porcine corpus luteum, respectively. However, we did not 
find mature relaxin immunostaining band in rat and pig atrial extracts, or porcine 
corpus luteum. This may be explained by the lower concentration of mature 
relaxin in atrial extracts. Several studies have demonstrated that prorelaxin 
exists in pregnant pig and rat ovaries, and prorelaxin concentration is much 
higher than mature relaxin (Soloff et al., 1992; Kwok et al., 1978; Frieden and 
Yeh, 1977) . It is known that most prohormones are biologically inactive or 
possess very low activity, however, several pro hormones were shown to have 
biologically active or immunoreactive forms, including high molecular weight 
form of ACTH, gastrin, glucagon, growth hormone, and parathyroid hormone 
(Kwok et al. , 1978). Prorelaxin in ovaries was also shown to be biologically 
active, but it is not clear whether this biological activity reflects the intrinsic 
relaxin activity (Soloff et al. , 1992; Kwok et al., 1978; Frieden and Yeh, 1977). 
Whether the prorelaxin of atrial extracts observed in this study has any 
biological activity needs to be further studied. 
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The function of cardiac relaxin is not yet well defined. Kakouris et al. 
( 1992) showed that exogenous relaxin has potent chronotropic and inotropic 
effects on isolated atrial tissue, suggesting that endogeneous relaxin may have 
the same function. Now, increasing evidences suggested that relaxin can act 
directly and indirectly as a tissue growth factor. Relaxin can promote the 
growth of the uterus during pregnancy (Sherwood, 1994), stimulate the 
differentiation of mammary gland cells (Bigazzi et al., 1992) and adipocytes 
(Bani et al. , 1989; Pawlina et al., 1989), and affect the maturation of brain 
during organogenesis (Osheroff and Ho-WH, 1993). These data suggest that 
endogeneous relax in may act via autocrine and/or paracrine routes to influence 
the growth and/or differentiation of atrial tissues. 
By immunohistochemistry technique, we also compared the locations of 
ANP and relaxin in the heart tissues of neonatal rat . We found that both ANP 
and relaxin localized in atria, especially in auricle, and no immunostaining was 
found in ventricles. Several studies indicated that no ANP immunostaining was 
found in ventricle of normal rat, but ANP immunostaining was present in 
ventricle of spontaneous hypertensive rat (SHR) (Ruskoaho and Vuolteenaho, 
1993). It will be very interesting to know whether relaxin exists in ventricles of 
SHR. 
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CONCLUSION 
Our results indicate that the precursors of relaxin store in the atria of rat 
and pig . The molecular weights of prorelaxin and preprorelaxin are about 1 8 -
kDa and 23-kDa, respectively . However, whether relaxin is actually synthesized 
in atria or whether it has any biological functions in this location remains to be 
studied. 
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APPENDIX A : IMMUNOHISTOCHEMISTRY 
Prepare solutions used for immunohistochemistry 
1. Stock T ris (good for 1 year) 
Place 121 .14g Tris base (THAM) in a 2000 ml volumetric flask. 
Add roughly 1 liter ddH20 and 60 ml concentrated hydrochloric 
acid. 
Adjust pH to 7 .6 w ith cone . HCI (6 ml) at room temperature. 
Bring total volume to 2000 ml. 
Label, date, initial and store in refrigerator. 
2. Working T ris pH 7 .6 (fresh) 
1: 10 dilution of stock Tris with ddH20 
3. 3 % hydrogen peroxide 
10 ml 30% H20 2 
90 ml methanol 
4 . Tris/PBS 1: 10 (good for 6 months) 
10 ml working Tris 
90 ml .01 M pH 7.2 PBS 
5. Phosphate buffered saline (PBS) .01 M pH 7 .2 (good for 1 year) 
0. 74 g Sodium phosphate dibasic . Anhydrous 
0.215 g Potasium phosphate monobasic 
3 .6 g Sodium chloride 
500 ml water 
Lable, date, initial, refrigerate . 
Procedure 
1 . Collect the hearts from 3-day-old rats 
2. Fix the heart tissues in 10% NBF for 18 hours 
3 . Dehydrate and embed tissues in paraffin 
10% Buffered formalin 1 5 minutes 
Alcoholic formalin 
70 % ethanol 
80 % ethanol 
95 % ethanol 
Absolute ethanol 
Absolute ethanol 
Absolute ethanol 
Xylene 
Xylene 
Paraffin # 1 
Paraffin #1 
Paraffin # 1 
15 minutes 
15 minutes 
15 minutes 
15 minutes 
15 minutes 
15 minutes 
30 minutes 
15 minutes 
30 minutes 
30 minutes 
15 minutes 
15 minutes 
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Paraffin #1 15 minutes 
4. Serial 5 µm section from blocks 
5 . Label all slides with number, antibody, and date 
6 . Select control and label with antibody and date 
7 . Place slides in the 57 °C oven 30 minutes 
8 . Deparaffinize and rehydrate tissue sections 
Xylene 5 minutes 
Xylene 5 minutes 
Xylene 5 minutes 
Absolute ethanol 3 minutes 
Absolute ethanol 3 minutes 
Absolute ethanol 3 minutes 
95 % ethanol 3 minutes 
70% ethanol 3 minutes 
Distilled water 3 minutes 
9 . Remove endogenous peroxidase activity 
Place slides in 3 % H20 2 solution 20 minutes 
1 O.Rinse 3 times with working Tris (5 min. each) 
11 . Block nonspecific reaction 
with 5 % normal goat serum 20 minutes 
1 2 .DO NOT RINSE . DRAIN, SHAKE and WIPE ONLY! 
13.lncubate sect ions with diluted primary antibody (Rabbit anti-
porcine relaxin antibody) 30 minutes 
14.Rinse 3 times with working Tris (5 min . each) 
15. lncubate sections with secondary antibody (Goat anti -rabbit lgG) 
30 minutes 
16.Rinse 3 times with working Tris (5 min . each) 
17. Incubate sections w ith Avidin-Biotin peroxidase complex (ABC) 
60 minutes 
18.Develop color with DAB 5 minutes 
Always watch development for each individual slide 
19.Rinse 2 times with ddH 20 2 into DAB waste container. 
20.Counterstain with hematoxylin 5 dips 
21.Rinse well with water and coverslip w ith aquamount 
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APPENDIX B: WESTERN BLOT ANALYSIS 
Prepare solutions used for Western blot analysis 
1. Acrylamide/Bis (30% total, 2.67 % cross-linked) 
29. 2 g acrylamide 
0.8 g N'N'-bis-methylene-acrylamide 
Make to 100 ml with distilled water. Filter, Wrap in foil, 
and store at 4 °C for maximum 30 days. 
2 . 1.5 M Tris-HCI, pH 8.8 
18. 1 5 g Trizma base 
Add 80 ml distilled water. Adjust pH with 1 N HCI. 
Make to 100 ml and store at 4 °C. 
3. 0.5 M Tris-HCI, pH 6.8 
6.0 g Trizma base 
Add 80 ml distilled water. Adjust pH with concentrated 
HCI. Make to 100 ml and store at 4 °C. 
4. 10% SOS (w/v) 
10 g SOS (Laurel sulfate) 
Gentle stir and bring to 100 ml with distilled water. 
5 . Sample buffer (SOS reducing buffer) 
2.0 ml distilled water 
0.5 ml 0 .5 M Tris-HCI , pH 6 .8 
0.4 ml glycerol 
0.8 ml 10% SOS 
0.2 ml 
0 .1 ml 
4.0 ml 
2-b-mercaptoethanol 
0 .05 % bromphenol blue 
Mix in hood. Store at room temp. for < 30 days. 
6 . 5X Running buffer, pH 8.3 
1 5 g Trizma base 
72 g glycine 
5 g sos 
Make to 1 liter with distilled water. pH should be 8.3-8 .5 
DON'T change pH. Dilute x 5 for use. 
7 . 1 OX Western buffer, pH 7 . 5 
60.55 g Trisma base (500 mM) 
116.88 g NaCl (2M) 
Make to 900 ml with distilled water. Adjust pH with 
cone. Hcl (about 37 ml) . Dilute x 10 and add Tween 20 
for use. 
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8 . Transfer buffer (25mM Tris, 192mM glycine, 20 % MeOH, pH 8.3) 
6 .06 g Tris 
28 .8 g glycine 
400 ml methanol 
Mix Tris, glycine, and methanol ; Add distilled water to 2 L 
DO NOT adjust pH 
Fresh 
Must be cold for run 
9 . 10% ammonium persulfate (fresh) 
100 mg APS 
Dissolve in 1 ml distilled water 
Procedure 
Casting discontinuous gel for PA GE 
1 . Assemble glass sandwich clamps in casting stand for gel 
preparation 
2 . Cast separating gel to glass sandwich down one of the spacers 
1 2 % separating gel preparation 
dd H20 
1.5 M Tris-HCI, pH 8 .8 
10% sos 
Acrylamide/Bis (30% stock) 
10% ammonium persulfate 
TEMED 
3 . Immediately overlay with isobutanol 10 ul 
4 . Allow to polymerize for 45-60 min. 
3 .35 ml 
2.5 ml 
0.1 ml 
4.0 ml 
0 .05 ml 
0.005 ml 
5 . Pour off isobutanol, wash one time w ith distilled water, remove 
remainder water with filter paper 
6. Cast stacking gel to fill remaining glass sandwich space 2/3 full 
4 % st acking gel preparation 
dd H20 
0 .5 M Tris-HCI, pH 6.8 
10% sos 
Acrylamide /Bis (30% stock) 
10% ammonium persulfate 
TEMED 
6 .1 ml 
2.5 ml 
0.1 ml 
1.3 ml 
0.05 ml 
0 .01 ml 
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7. Immediately place comb into sandwich at angle; gel solution should 
flow out over edge to prevent air bubble formation; align comb. 
8. Allow to polymerize for 45-60 min . 
9. Remove comb 
Running discontinuous gels 
1 . Assemble upper buffer chamber 
2 . Dilute sample with sample buffer; heat at 95 °C for 3-5 min. 
3. Load sample wells 
4 . Add 1 X running buffer to upper buffer chamber to a level 1 /2 way 
between short and long plates. DO NOT overfill. 
5. Pour remainder of running buffer into lower chamber to cover 
> 1 cm of the gel . 
6 . Place lid in correct orientation on top of lower buffer chamber 
7 . Turn on power; constant voltage 200 volts 
8 . Run electrophoresis for 30 min. 
9 . Turn off power supply and disconnect leads 
1 O.Twist one spacer to remove upper glass plate; remove gel with 
razor blade 
Transfer of proteins from gel to nitrocellulose membrance 
1. Wash gel 3 times in cold transfer buffer; 5 min. each wash 
2 . Wearing gloves; cut nitrocellulose paper into 5.5x8.5 cm pieces 
3 . Slide nitrocellulose paper at 45 degree angle into large dish with 
transfer buffer; soak 15-30 min . 
4. Make "sandwich"; put this sandwich into gel holder 
+ 
I I Fiber pad 
I I Filter paper 
Gel I I I I -holder Nitrocellulose I I I I membrane 
I I 
Gel 
5. Place gel holder in buffer tank 
6. Set buffer tank on magnetic stirrer; fill tank with cold transfer 
buffer to cover gel /paper; replace lid and attach leads. 
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7 . Turn on power; constant voltage 100 volts. 
8 . Transfer for 1.5 hours; turn off power; wash membrance 2 times 
with Western buffer; 10 min. each wash. 
Western blot 
1. Block nonspecific reaction with 1 % BSA for 18 hours at 4 °c. 
2. Wash membrane 2 times with Western buffer; 10 min . each wash 
3. Incubate membrane with primary antibody (Rabbit anti-porcine 
relaxin antibody) for 1 hour with gentle stir at room temperature . 
4. Rinse membrane 1 time with Western buffer; then wash 
membrane 2 times with Western buffer; 10 min. each wash . 
5. Incubate membrane with secondary antibody (Biotinylated goat-
antirabbit lgG) for 1 hour with gentle stir at room temperature. 
6. Rinse membrane 1 time with Western buffer; then wash 
membrane 2 times with Western buffer; 10 min. each wash. 
7 . Incubate membrane with streptavidin-biotinylated alkaline 
phosphatase complex 1 hour with gentle stir at room temperature. 
8. Rinse membrane 1 time with Western buffer; then wash 
membrane 4 times with Western buffer; 5 min. each wash. 
9. lmmers the membrane in the color development solution (5-
bromo-4-chloro-3-indolyl phosphate/nitroblue tetrazolium) for 
5 min. with gentle stir at room temperature. 
1 O.lmmerse the membrane in distilled water to stop the color 
development for 10 min. Change the water two times during the 
10 min. period. 
11 .Dry the membrane on filter paper 
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APPENDIX C: AVIDIN-BIOTIN PEROXIDASE COMPLEX 
METHOD TO DETECT RELAXIN 
Substrate 
(DAB) 
Product 
Avidin-Biotin-Peroxidase 
~ ~------ Complex (ABC) 
 Biotinylated goat 
~ ---- --- anti-rabbit lgG 
Rabbit anti-porcine 
------------- relaxin antibody 
Ii ~ 
/\ /\ ---- --- ---- Relaxin in the ti ssue 
63 
APPENDIX D: STREPTAVIDIN-BIOTINYLATED-ALKALINE 
PHOSPHATASE COMPLEX METHOD TO DETECT RELAXIN 
Substrate Product 
Streptavi din-bi oti nyl ated 
-alkaline phosphatase 
complex 
Biotinylated goat 
--- anti-rabbit lgG 
Rabbit anti-porcine 
--------- relaxin antibody 
~ ~ Relaxin separated 
A A --- ----- in the gel and blotted _ _ on the membrane 
